BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TONIX PHARMACEUTICALS HOLDING CORP. — Receipts Report

LD-2 disclosure · 4th Quarter - Report

TONIX PHARMACEUTICALS HOLDING CORP.

via BURRELL INTERNATIONAL GROUP LLC

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 16, 2024Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: TONIX PHARMACEUTICALS HOLDING CORP.
Description: Pharmaceutical Company
Location: New Jersey · United States of America

Registrant

Firm: BURRELL INTERNATIONAL GROUP LLC
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products
LobbyistsDEBORAH LYNN BURRELL · KRISTIN STEVENS
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.